Pricing Log in Create free account
Saturday 17 October 2026 Export WST’s income statement to Excel — free account

West Pharmaceutical Services, Inc.

WST Healthcare Medical Instruments & Supplies

West Pharmaceutical Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.1 billion, up 6.25% from fiscal 2024. In the quarter to June 2026, revenue grew 13.8%, EPS grew 19.2%, free cash flow fell 20.7% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

382.92 0.10 −0.03%
Market cap
$27.0B
P/E
48.7×
Fwd P/E
37.3×
Dividend yield
0.23%
F-score
8/9
Altman Z
13.89
Beneish M
−2.79
Dividend safety
100/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

West Pharmaceutical Services, Inc. (WST) EV/EBITDA

Alert me on EV/EBITDA

As of 16 October 2026, West Pharmaceutical Services, Inc. (WST) trades at a EV/EBITDA of 31.2×. Over the past ten years it has ranged from 13.0× (February 2015) to 47.9× (September 2021); the current reading is higher than 73% of that period. That is above the Medical Instruments & Supplies industry median of 14.6× and above the Healthcare sector median of 9.2×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 25.5× (21.66%)
FY2024 32.6× 5.45%
FY2023 30.9× 57.60%
FY2022 19.6× (50.08%)
FY2021 39.3× (1.52%)
FY2020 39.9× 45.78%
FY2019 27.4× 32.73%
FY2018 20.6× (9.14%)
FY2017 22.7× 4.83%
FY2016 21.6× 10.19%

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 29.2× 37.09%
Mar 2026 21.3× (16.48%)
Dec 2025 25.5× 3.81%
Sep 2025 24.6× 18.08%
42 more quarters

Against its own ten years

Low 13.0× High 47.9×
Ten-year median 25.7×
Current reading's percentile 73

EV/EBITDA against peers

Company EV/EBITDA
MDLN Medline Inc. compare 4.1×
SOLV Solventum Corporation compare 7.6×
ALC Alcon compare 13.0×
BDX Becton, Dickinson and Company compare 13.7×
BAX Baxter International Inc. compare 14.0×
COO The Cooper Companies, Inc. compare 14.6×
RMD ResMed Inc. compare 15.8×
WST West Pharmaceutical Services, Inc. 31.2×
RGEN Repligen Corporation compare 60.2×
Medical Instruments & Supplies industry median 14.6×
Healthcare sector median 9.2×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on WST